Utah Medical Products (UTMD) Free Cash Flow (2010 - 2026)

Utah Medical Products' Free Cash Flow history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 30.4% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $13.0 million, a 4.45% decrease from a year earlier, with the FY2025 full-year figure at $14.3 million, down 1.92% from the prior year.
• Free Cash Flow slipped to $3.0 million in Q1 2026 per UTMD's latest filing, from $3.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $6.9 million in Q1 2023 and bottomed at $2.7 million in Q2 2024.
• The 5-year median for Free Cash Flow is $4.6 million (2023), against an average of $4.3 million.
• Across the five-year window, Free Cash Flow surged 42.9% in 2023 and sank 44.14% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at $5.6 million in 2022, then fell by 7.09% to $5.2 million in 2023, then sank by 44.14% to $2.9 million in 2024, then gained by 15.03% to $3.4 million in 2025, then retreated by 11.55% to $3.0 million in 2026.
• Per Business Quant, the three latest UTMD Free Cash Flow figures stand at $3.0 million (Q1 2026), $3.4 million (Q4 2025), and $3.9 million (Q3 2025).